Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Comment by tuesdaynightridon Oct 30, 2015 6:39pm
143 Views
Post# 24245628

RE:RE:RE:RE:Clinical experience and outcome of PDT in early lung cancer

RE:RE:RE:RE:Clinical experience and outcome of PDT in early lung cancerSo I ask a simple question, which was basically, "did Roger ever explain the need for his TLC-3200 to activate TLD-1433 given that a host of PDC's have previously been activated with prior art."

Of course, I was hoping that one of the brain surgeons who normally support Bencro might want respond to that particular question (i.e. Skier, coalbet, macer, etc). I had only had one request and that was that the nitwit Bencro not respond because he not only didn't have the mental capacity to answer the question but has also never been successful at staying on topic.

So, low and behold, the only response I get is from that nitwit Bencro who of course could not answer the question.
Bullboard Posts